IL33 and neoplasm: Using a new GEMM that enables spatiotemporally controlled suppression of epithelial Il33 expression during Kras-initiated neoplasia, we functionally demonstrated that the loop initiated by epithelial IL-33 directs exit from a highly plastic inflammation-induced epithelial state, enabling progression towards typical neoplasia.